Steris (STE) EBT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 244.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 584.00 |
| Dec 31, 2025 | 54.00 |
| Sep 30, 2025 | 267.00 |
| Jun 30, 2025 | 298.00 |
| Mar 31, 2025 | -10.00 |
| Dec 31, 2024 | 208.00 |
| Sep 30, 2024 | 208.00 |
| Jun 30, 2024 | -40.00 |
| Mar 31, 2024 | -245.00 |
| Dec 31, 2023 | -81.00 |
| Sep 30, 2023 | -202.00 |
| Jun 30, 2023 | 21.00 |
| Mar 31, 2023 | 565.00 |
| Dec 31, 2022 | 33.00 |
| Sep 30, 2022 | 712.00 |
| Jun 30, 2022 | 1,688.00 |
| Mar 31, 2022 | -531.00 |
| Dec 31, 2021 | -215.00 |
| Sep 30, 2021 | -1,021.00 |
| Jun 30, 2021 | -1,923.00 |
| Mar 31, 2021 | -246.00 |
| Dec 31, 2020 | -6.00 |
| Sep 30, 2020 | 177.00 |
| Jun 30, 2020 | 197.00 |
| Mar 31, 2020 | 69.00 |
| Dec 31, 2019 | 900.00 |
| Sep 30, 2019 | 189.00 |
| Jun 30, 2019 | 126.00 |
| Mar 31, 2019 | -2,353.00 |